Merck Czech Republic - Equity And Liabilities

Merck CR`s Equity And Liabilities reached 774 CZK mil in 2017. This is 6.64 % more than in the previous year.

$1.99

Buy Equity And Liabilities data for Merck Czech Republic.

$19.99

Buy all data for Merck Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...             227 259 218 267 276    
Bayer Czech Republic ... ... ...                 774 572 698 682 830    
GlaxoSmithKline Czech Republic ... ... ...                 3,166 2,418 2,374 2,019 2,107    
Merck Czech Republic ... ...                   445 500 544 476 530    
Novartis Czech Republic                       1,401 1,514 1,507 1,646 1,911    
Pfizer Czech Republic ... ...                   2,885 2,530 2,812 2,922 1,937    
Roche Czech Republic ... ... ...                 2,238 2,344 2,245 2,317 2,548   ...
Sanofi-Aventis Czech Republic ... ... ... ...               3,167 3,297 2,694 2,348 2,635    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 95.4 110 251 284    
Walmark ... ... ...                 1,719 1,596 1,964 2,096 1,607